Mutares SE & Co. KGaA (MUX) Earnings Call Transcript & Summary

May 14, 2020

Deutsche Boerse Xetra DE Financials Capital Markets earnings 37 min

Earnings Call Speaker Segments

Jessica Albert

executive
#1

Good afternoon, everyone, and welcome to the earnings call covering the first quarter of 2020. Joining us today are our CFO, Mark Friedrich, and our CIO, Johannes Laumann, who will walk you through the results and the most relevant events from the first quarter of this year. Once the presentation wraps up, we will be glad to take your questions. The presentation being shown can be found on our website. Before we begin, I want to remind you that this call and presentation include forward-looking statements, including projections that may not turn out the way we currently expect. So I kindly ask you to review the precautionary warning regarding forward-looking statements that appears in the materials on our website. With that, let me turn things over to Johannes.

Johannes Laumann

executive
#2

Good afternoon, everyone. I'd like to walk you through the business model, with a bit of a look back at the transaction we completed in 2020 and the closings that have taken place so far in the first quarter. Let me begin with an overview of the business model, which we'd like to present to you this way: we place our realignment, optimization, and harvesting in the context of what we're aiming to achieve here at the holding. So consulting income, cash flow, growth, and dividends are our primary focus once we've acquired a company. And beginning with consulting income, then moving to dividends, our goal is to reflect a 5x return on invested capital, which in the harvesting phase can be targeted — or is targeted, as an idea — to rise to 5 to 10 across the entire life cycle of our portfolio companies. How we achieve this comes down to our key assets, and our USP is value creation. That means the consideration of taking calculated risks, evaluated by our M&A team along with our extensive operational experience, which we currently have under our wings within — at the close of quarter 1, 64 consultants on our payroll.

Johannes Laumann

executive
#3

We’re asking for extra funding from the salary so we can bring about the turnaround of the business. After that, together with management and our own people, we carry out these successful turnarounds, and we hold on to the DNA that we have. One important point to know: management owns over 40% of the shares. That is also unchanged from the prior year. Here you can see a track record that gives us the foundation for our business model. You’re looking at the Vintage portfolio and our portfolio outlook. This was also presented in a similar way during the bond presentations. At present, the Vintage portfolio has contributed a return on invested capital of 5.6x, which is mainly driven by dividends as well as consulting income. That’s because return on invested capital is one of our main KPI drivers, along with return on equity. On book equity, as you can see on the chart here, we are concentrating on those 2 numbers going forward. As a reference and in comparison with book equity, we have included a NAV at the end of last year of EUR 220 million, which will be discontinued from now on, and we will focus on ROI -- ROE, sorry, and ROIC.

Johannes Laumann

executive
#4

Turning to the Q1 2020 highlights: we carried out 2 structured, planned exits. We sold off Balcke-Dürr's Polish operations, and through a management buyout we divested BEXity's Czech business during the first quarter. We also made new acquisitions — one add-on deal on the strategic side for Balcke-Dürr in Italy with Loterios, which broadens the portfolio and brings new customer entries for Balcke-Dürr. Then we signed 2 further acquisitions with Nexive, which we already discussed on the annual call, and last Friday we signed a takeover of an automotive supplier from Cooper Standard — a corporate carve-out — and I'll say a few words about that later. On additional progress, the Ruukki add-on completes the Donges Group so it becomes the #1 player in the NORDEC market and a very significant player in steel structures across the whole of Europe. Under the new brand, NORDEC, we combined the newly acquired Ruukki construction with the existing Normek brand. As you know, in Q1 we also successfully placed the EUR 50 million bond capital raise. And we announced a distribution of EUR 1 dividend at our annual meeting, which takes place next Monday.

Johannes Laumann

executive
#5

Turning now to the 3 acquisitions we've signed. During the annual call, we discussed the add-on of Balcke-Dürr and Nexive, and we expect those to close in Q2 of this year. Then last Friday, we announced that we've signed a project known as Gemini — a platform investment from Cooper Standard that fits really, really well with our Elastomer Group. The synergies take in their main facilities in Poland, Italy and India. We have a solid plan in place to turn this business around, and it will also deliver synergies with Elastomer, forming a nice group at that point. Also in quarter 1, it wasn't just 3 acquisitions that were signed — we closed 3 acquisitions as well. We closed PrimoTECS, Automotive supplier Board from TEC 4. We closed the keeeper tableware acquisition from the Metsä Group, which had been signed. Both of those transactions were signed just before Christmas. And last but not least, following an intense merger control process, we closed NORDEC, formerly Ruukki Building System. The closing happened at the end of April. Signing had already taken place last year, in July. That brings us to the portfolio overview, where you can see, with the Gemini project and PrimoTECS, an increase in Automotive & Mobility, and I also believe that as an impact of COVID-19, we're seeing a lot of potential and a lot of good opportunities within the second half of this year.

Johannes Laumann

executive
#6

In engineering and technologies, we're also seeing plenty of opportunities, particularly with what Balcke-Dürr brings in, along with platform investments and the goods and services from BEXity, keeeper, and Cenpa. On the operational side, we've had beneficiaries of COVID-19, but we're also seeing quite a few approaches regarding potential add-on acquisitions for those companies. So looking ahead at the portfolio, I see what may be once-in-a-lifetime opportunities on the buy side in the second half of the year, yet I also see fairly good opportunities on the sell side when it comes to companies that ran quite stably through the COVID-19 crisis. That wraps up the Q1 update on the portfolio. I'll now hand things over to Mike Friedrich for the financial part.

Mark Friedrich

executive
#7

Thanks, Johannes. As usual, we'll begin the financial portion with a review of the key financial figures, after which we'll turn to the consolidated statement of profit and loss along with the balance sheet, then walk through the various developments across our segments, and wrap up that section with a fresh look at how the life cycle has developed. Let's start with the key financial data. For the first time, we recorded sales above EUR 300 million within a single quarter, driven largely by the M&A activity seen in 2019 and at the start of 2020. Group EBITDA, shaped heavily by that M&A activity, will, as we'll see, come mostly from bargain purchase income, principally from the PrimoTECS transactions. Conversely, Q1 is consistently the toughest quarter for us, because a few of our larger businesses post a weaker Q1 — Balcke-Dürr Group in particular — so that, combined with the new acquisitions contributing largely negative results, leaves us with group adjusted EBITDA of minus EUR 10 million. Thanks to the bond, group cash and cash equivalents rose substantially during Q1 to more than EUR 140 million, while the equity ratio declined slightly. Now let's look at the Q1 P&L.

Mark Friedrich

executive
#8

Sales rose sharply versus Q1 2019, and that's because of the new acquisitions — all of them were acquired after Q1 in 2019 and during Q1 2020. Turning to the next page, adjusted EBITDA reflects the pattern we typically observe when we bring a large number of new companies on board. We booked a high income from bargain purchases here, exceeding EUR 50 million in Q1. At the same time, we have only just begun restructuring at most of these businesses — most of these new companies — and we also faced some constraints from COVID-19 travel restrictions. As I said earlier, the income from bargain purchase stems mainly from PrimoTECS, at roughly EUR 40 million, and all of it is preliminary. On the other side, keeeper tableware, which amount — which accounts for the bulk of this bargain purchase income. The deconsolidation from the exit that Johannes referred to will be recorded in Q2, given that those transactions closed in Q2. Moving to Page 15, the balance sheet: as always, whenever we complete many transactions, total assets go up. Here, that's a little over 20%. What we see is that financial liabilities, both long and short term, have grown considerably — largely driven by the bond raise, but also by the debt we group here for IFRS 16, which represents about EUR 120 million in noncurrent liabilities and roughly EUR 30 million in the other financial liabilities.

Mark Friedrich

executive
#9

Moving on to how the segments developed, and they differ quite a bit, beginning with Automotive & Mobility. As everyone likely already knows, this is the toughest segment. Sales rose substantially, driven largely by the new acquisitions of Plati, KICO and PrimoTECS, which contributed roughly EUR 40 million in Q1 2020. Conversely, as you may have heard yesterday, STS sales fell by about EUR 20 million in Q1. That heavy M&A activity shows up in EBITDA, which is strongly positive and up considerably versus last year. Adjusted EBITDA, though, is negative because those new acquisitions all contributed negatively in Q1, and combined with the STS decline, we show minus EUR 3 million here. Going forward, the COVID-19 situation will be challenging, or is challenging, in Q2, and we'll watch how it unfolds — particularly in Automotive, where we, like pretty much the whole industry, are heavily impacted by OEM plant shutdowns. The Engineering & Technology segment is rather mixed, with Balcke-Dürr and Eupec contributing negatively on adjusted EBITDA while Donges and Gemini contribute positively.

Mark Friedrich

executive
#10

At this point, finishing up part of the Donges Group restructuring gives us a favorable comparison with last year. Conversely, Balcke-Dürr experienced a fairly tough first quarter, particularly measured against last year, when the company—or rather the group—always operates in a peculiar setting during Q1, because the bulk of services and service contracts begin in Q2. So business isn't—business activity isn't especially strong in Q1. And along with the additional shutdown in Italy, which now represents a larger portion of the Balcke-Dürr Group, they suffered a bit of a reverse in Q1 versus last year. Conversely, Gemini in particular also performed quite well in Q1 relative to the Donges Group. There, we observe that wrapping up the 2019 restructuring is now paying off for Gemini with positive EBITDA, and we think the same will hold for Gemini in the following quarter as well. Turning to the Goods & Services segment, which saw a substantial rise in sales. During Q1 2019, we had just 2 companies, Klann and Cenpa, that made up this EUR 8 million. And today, with these larger groups, BEXity's sales in particular are climbing substantially.

Mark Friedrich

executive
#11

Because we’ve made a few new acquisitions, such as BEXity, keeeper and Cenpa, adjusted EBITDA came in lower than last year, and that’s fairly typical. We’ve only just begun, particularly with the restructuring at BEXity. To give you one number: BEXity weighs on adjusted EBITDA by roughly EUR 2 million negatively. That takes us to the life cycle schedules for our portfolio. So versus the segment presentation, we’ve now rearranged our portfolio into the different life cycle stages that Johannes laid out at the start. Let me begin with what changed relative to the end of 2019. We shifted Plati and keeeper from realignment into optimization. And we moved — in effect we swapped Balcke-Dürr and Donges, with Donges going up and Balcke-Dürr going down into optimization. Our reasoning was that we had sold the Polish business, which was quite positive. On the other side, Balcke-Dürr has acquired Loterios, a new company, and now has more of an optimization effort ahead of the group, where they must consolidate the Italian locations, which is why we view this company as being more in the optimization phase. On the other hand, completion of the Ruukki transaction moved the Donges Group upward, since the restructuring and integration went quite well.

Mark Friedrich

executive
#12

We believe the Ruukki integration was already quite well prepared in Q1, and that is why we see Donges Group as being in the harvesting stage now. On the other hand, you can see here that in our business model, realignment always makes a negative contribution when it comes to adjusted EBITDA. That is the case in Q1 as well, and we will see this throughout the year 2020. Optimization is also negative. That EUR 5 million of adjusted EBITDA last year is pretty much solely tied to the Balcke-Dürr Group. So Balcke-Dürr had a EUR 5 million adjusted EBITDA loss in Q1, and the other one combined is pretty much breakeven. On the other hand, harvesting contributed slightly positively, especially nice when we would look at it. Compared to last year, Donges Group in particular moved from a negative contribution to a positive one. And Elastomer was also able to contribute positively in Q1, which might change in Q2. And with that, I hand over again to Johannes for the close out.

Johannes Laumann

executive
#13

Okay, thank you so much, Mark. Before we move into Q&A, just a quick recap and a brief summary. So with the current portfolio, we anticipate a difficult COVID-19 environment. At the same time, naturally, as I mentioned earlier, for M&A activity in the second half of the year this can be a once-in-a-lifetime opportunity. We've already signed 3 transactions. We've already completed 2 exits. So both the pace of deals and the count of deals match the prior year, and I'm looking toward the second half very positively. So the team here is ready, and we're seeing more and more opportunities entering the pipeline. The targeted revenue is as expected, and as already stated, we anticipate more than EUR 1.5 billion for this financial year, which is, of course, primarily driven by the acquisitions we completed in the second half of last year, and which we have also completed at the start of this year. If you'd like to name them, it's Nexive, it's BEXity, it's the Cooper Standard acquisition, which is close -- all of them close to EUR 200 million in sales or even slightly above, and then we have PrimoTECS with EUR 100 million of sales and the other add-on acquisitions at closer to EUR 50 million.

Johannes Laumann

executive
#14

M&A is what pushes that revenue higher in a big way. And as we've consistently said, our aim is to keep the dividend capacity intact while being both highly appealing and aggressive on that front too. As you observed, return on invested capital will serve as our primary trigger, and that has a direct bearing on the capacity to pay dividends. Finally, we'd like to provide an outlook. In October of this year, we will once again host a Capital Markets Day. This will be the second edition, following last year's. An update will reach you over the coming weeks and months. It's on the schedule. You're welcome to make a wild guess, but that's Frankfurt's skyline. So it is once more planned for Frankfurt. The venue will be communicated once we know whether we'll hold it digitally or hold it in person. As things stand right now, it's still planned to be in person in Frankfurt, but we will announce if it gets converted to digital. Many thanks. With this slide, I'll return the floor to the moderator for the question-and-answer sessions.

Operator

operator
#15

And kicking off the questions, we have Zafer Rüzgar from Pareto Securities.

Zafer Rüzgar

analyst
#16

Zafer Rüzgar from Pareto Securities here. I've got 3 questions, and perhaps we can go through them one at a time. To start, on the pandemic and how it affected the figures you reported — we haven't noticed much of an effect on those reported numbers. Could you perhaps give us some insight into how revenues and earnings were impacted? You brought up the effect in the automotive segment, but are there also segments that actually gained from the pandemic?

Johannes Laumann

executive
#17

I'll do my best to answer that. It's somewhat hard, since the question suggests I can look ahead and predict whether it will return or when it will end, and that's rather difficult to do. The biggest effect, in fact, shows up in the automotive segment. If you look at production volumes, which the OEMs have also — this closed in April — you see output falling by 80%, 90%, and that naturally hits automotive suppliers directly, like the STS Group, like PrimoTECS, or KICO with Elastomer and Plati; we're also active in other businesses as well. So the blow there isn't as severe. Second, we have companies such as Donges Group, where the picture is somewhat mixed. Some subsidiaries are affected, such as Kalzip, where the travel ban or the travel restriction directly impacts revenues and profit. Conversely, infrastructure projects are now increasingly coming through, which benefits Donges SteelTec. So there, we have somewhat of a pair on this. And then, naturally, we also have beneficiaries of this. We didn't know that when we bought Keeeper tableware.

Johannes Laumann

executive
#18

Actually, they do make toilet paper, and that has clearly been a big positive during the pandemic. So we're seeing both sides. But the biggest blow is definitely in our portfolios on the automotive side. Revenue is difficult to forecast. For the remainder of the year, the OEMs are expecting output to be 30% below the original level. That's what we're currently using for our plans and budgets as well. So we simply track the OEMs' projections, which come in at roughly 30% lower output for the rest of the year versus the original budgets.

Zafer Rüzgar

analyst
#19

All right, that's fine. Perhaps this ties into the recent acquisitions and the bargain purchases you expect from them. In Q1 you recorded EUR 54 million from 3 acquisitions, and if I look at the recent acquisitions that haven't closed yet, together they're, I'd guess, twice the size of those 3 acquisitions. Would it be fair to assume that in Q2 you'll likely book bargain purchases exceeding EUR 100 million?

Johannes Laumann

executive
#20

Well, the final booking obviously also ties back to the purchase price allocation for that same item, but if you take your figure and allow us a bit of leeway in the 20% to 25% range, you might not be too far off.

Zafer Rüzgar

analyst
#21

All right, so regarding Balcke-Dürr — you brought up the softness there. How much of that softness stems from operations, and how much comes from the recent acquisitions? Also, should we expect Balcke-Dürr's weaker results to carry into the following quarter?

Johannes Laumann

executive
#22

To address the last question first: do we anticipate even softer results in the upcoming quarter? No, we don't. And the — what happened was — Balcke-Dürr came under pressure from 2 factors. One was a delay to a project at the German entity. The other involved the Loterios acquisition, the STS deal from last year, and your original market, the Italian business. With the Polish business now exited, the business exposure of the Balcke-Dürr Group — specifically Balcke-Dürr's exposure in Italy — rose significantly. And as you're aware, Italy was in a full lockdown during March. So revenue there was essentially 0. On top of that, a major project postponement in Germany, on the erection and commissioning side, weighed heavily as well. So it was a combination of Italy and that German project delay, which will be made up, perhaps not entirely in Q2, but we view the 2020 outlook for Balcke-Dürr as fairly solid. Q1, though, was under severe pressure because of those factors. Italy has now reopened, however. The factories are operating at reduced capacity, yet they are running once more, so contributions from there will definitely show up in Q2.

Zafer Rüzgar

analyst
#23

Alright, and perhaps just a brief one. On an annual basis, what does your consulting income come to with the most recent transaction?

Johannes Laumann

executive
#24

The figure should land somewhere between EUR 20 million and EUR 25 million, and it will be nearer to EUR 25 million.

Operator

operator
#25

Our following question comes from Holger Steffen at SMC Research.

Holger Steffen

analyst
#26

I've got a few more questions. To start, thanks for the thorough Q1 report. Thanks to a number of acquisitions, you've posted strong growth. As I recall, you typically lay out how consolidation affected revenue. Could you give us that number?

Mark Friedrich

executive
#27

Are you asking about the revenue that came from acquisitions?

Holger Steffen

analyst
#28

Yes.

Mark Friedrich

executive
#29

All right. Just a moment. Is there anything else you'd like to ask?

Holger Steffen

analyst
#30

Yes. I have a few questions of my own. So I'll begin with one more. You mentioned that buying PrimoTECS generated income from bargain purchases of almost EUR 40 million. Is it fair to assume that this points to a very large operating loss at that company?

Johannes Laumann

executive
#31

It's more a case of an exceptionally strong asset base than of a high loss.

Holger Steffen

analyst
#32

Okay, so I'm a bit surprised, then, that the realignment companies lost only EUR 6 million in Q1 in total, given that you acquired large companies. So how would you explain that?

Johannes Laumann

executive
#33

To start with—and after this I might pass things over to Mark—the first point is that we negotiated effectively, Holger. Then, I think, when you look at PrimoTECS and BEXity as the 2 major acquisitions in this instance, BEXity performed quite strongly in Q1. And it wasn't hit too hard by COVID-19. And as mentioned, PrimoTECS isn't a company with heavy losses. There was a different strategic rationale behind the sale of this company, coming from TEC 4 Group.

Mark Friedrich

executive
#34

Acquisitions brought in roughly EUR 100 million in sales.

Holger Steffen

analyst
#35

EUR 100 million. All right. You've mentioned synergies involving Elastomer and the Cooper Standard businesses. Are you intending to merge those two companies? And how does Plati fit in, since it also has synergies with Elastomer?

Johannes Laumann

executive
#36

We maintain legal separation between the companies — or rather, the companies are separate, to put it that way. That said, operational synergies do exist in raw material supply, in combined sales, and in combined administration. Where Plati is concerned, the synergies lean more toward geography than toward product, whereas the synergies from the Cooper Standard purchase and Elastomer lean more toward product and customer.

Holger Steffen

analyst
#37

All right, so my final question is about how liquid your companies are. Yesterday STS reported a favorable liquidity trend for the first quarter. How does KICO actually stand right now? And after several weeks of corona, are there additional companies facing a tough liquidity position?

Mark Friedrich

executive
#38

I'll take the first part of that question. It's a tough one, and the same goes for KICO. Right now, the OEMs have begun reopening their plants, but only at a very low level. It resembles more of a letter — or a start — than an outright jump. And we're working alongside every portfolio company, not just KICO. With all of them, we're focused on securing liquidity by every available means, involving all stakeholders — suppliers, customers, officials — and at times that includes us. It's a kind of situation where, across the entire group, we need to provide support; for instance, we also backed the closing of Ruukki for the Donges Group. That was planned, and we supported it. They also mentioned that because of lower activity at businesses like Kalzip, they're seeing somewhat reduced liquidity. So it applies to pretty much every portfolio company — apart from those that likely benefit from the situation, such as SunPower, where we have essentially no problem. But for all the rest, we've put quite strong measures in place to secure liquidity.

Holger Steffen

analyst
#39

Has any company obtained loans from public health programs during this period?

Mark Friedrich

executive
#40

Just — really, it's only the STS Group in France. Apologies — the STS Group in France, though Eupec had also already gotten the '20 loan.

Operator

operator
#41

Our next question comes from Felix Eisel at Conduction Capital.

Felix Eisel

analyst
#42

Conduction Capital — I believe I got the spelling wrong there. A quick question for Johannes Laumann one. You mentioned the attractive opportunities you're seeing on the buy side, which is probably obvious given where things stand right now, but also the attractive opportunities on the sales side. Could you perhaps expand on that — where does that instinct, or that statement, come from? What are you seeing? Are potential buyers approaching you about assets that look especially stable on your end? Or how did that statement come about?

Johannes Laumann

executive
#43

It's hard to give too much detail on that, Felix. We're seeing possible approaches coming from the buyer side, the potential buyer side. And we're seeing, after a good deal of quiet over the past months and years, the Chinese returning to the European market and trying to find companies. That's the second point. And third, we do have active processes underway in which we're seeking a possible divestment of companies, and we're already getting feedback there.

Operator

operator
#44

Right now, there are no more questions coming in. <<operator_script>> Since nothing further has come up, I'd like to return the floor to you so you can offer a few closing comments.

Jessica Albert

executive
#45

We appreciate you all joining us on this call today, and we hope the remainder of your day goes wonderfully and we'll see you again next time. Please take care, and farewell.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Mutares SE & Co. KGaA transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

For developers and AI pipelines

Programmatic access to Mutares SE & Co. KGaA earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Mutares SE & Co. KGaA or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.